Uroflowmetry is a simple, non-invasive diagnostic tool that offers critical insights into a patient’s urinary flow dynamics. As endorsed by the American Urological Association (AUA), clinicians should consider uroflowmetry prior to any intervention for lower urinary tract symptoms (LUTS) or benign prostatic hyperplasia (BPH) as a Clinical Principle.[1] Beyond measuring flow rates, uroflowmetry provides additional diagnostic value by analyzing the shape of the flow curve and the duration of voiding. These parameters serve as effective screening tools for LUTS, helping to characterize voiding dysfunction. This data is invaluable in counseling patients about surgical outcomes and setting realistic expectations. If surgical intervention becomes necessary, uroflowmetry offers a reliable method to compare pre- and post-operative flow rates. These comparisons provide objective measures of treatment outcomes, enabling clinicians to assess the success of therapy in reducing obstruction and improving patient quality of life. Below is an overview of how the American Urological Association (AUA) recommends its use across various urological conditions: including Benign Prostatic Hyperplasia (BPH), Urethral Stricture, Neurogenic Lower Urinary Tract Dysfunction (NLUTD). References  1/ "Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline," 2023